These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32690108)

  • 21. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
    Nagill R; Kaur S
    Vaccine; 2010 May; 28(23):4002-12. PubMed ID: 20093205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases.
    Agallou M; Dotsika E; Frydas S; Karagouni E
    J Biol Regul Homeost Agents; 2014; 28(1):41-52. PubMed ID: 24750790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of some antigenic fractions of Leishmania major on nitric oxide production and IL-12 secretion by murine peritoneal macrophages.
    Mirshahidi S; Turhan A; Pişkin AK; Imir T
    Immunol Lett; 1998 Feb; 60(2-3):189-92. PubMed ID: 9557962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
    Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
    Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events.
    Bhattacharyya S; Ghosh S; Jhonson PL; Bhattacharya SK; Majumdar S
    Infect Immun; 2001 Mar; 69(3):1499-507. PubMed ID: 11179319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum.
    Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ
    Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
    Khoshgoo N; Zahedifard F; Azizi H; Taslimi Y; Alonso MJ; Rafati S
    Vaccine; 2008 Oct; 26(46):5822-9. PubMed ID: 18804512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory activities of chitin microparticles on Leishmania major-infected murine macrophages.
    Dehghani F; Haji Molla Hoseini M; Memarnejadian A; Yeganeh F; Rezaie AM; Khaze V; Sattari M; Darbandi Tamijani H; Labibi F; Mossaffa N
    Arch Med Res; 2011 Oct; 42(7):572-6. PubMed ID: 22154683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
    Holzmuller P; Cavaleyra M; Moreaux J; Kovacic R; Vincendeau P; Papierok G; Lemesre JL
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):247-57. PubMed ID: 15963823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
    Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
    Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription of innate immunity genes and cytokine secretion by canine macrophages resistant or susceptible to intracellular survival of Leishmania infantum.
    Turchetti AP; da Costa LF; Romão Ede L; Fujiwara RT; da Paixão TA; Santos RL
    Vet Immunol Immunopathol; 2015 Jan; 163(1-2):67-76. PubMed ID: 25466388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide production in mouse peritoneal macrophages enhanced with glycyrrhizin.
    Kondo Y; Takano F
    Biol Pharm Bull; 1994 May; 17(5):759-61. PubMed ID: 7920451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
    Ni YF; Kuai JK; Lu ZF; Yang GD; Fu HY; Wang J; Tian F; Yan XL; Zhao YC; Wang YJ; Jiang T
    J Surg Res; 2011 Jan; 165(1):e29-35. PubMed ID: 21074783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-kappaB activation, and nitric oxide production.
    Anstead GM; Chandrasekar B; Zhang Q; Melby PC
    J Leukoc Biol; 2003 Dec; 74(6):982-91. PubMed ID: 12960263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
    Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
    Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.
    de Moura TR; Santos ML; Braz JM; Santos LF; Aragão MT; de Oliveira FA; Santos PL; da Silva ÂM; de Jesus AR; de Almeida RP
    Parasitol Res; 2016 Feb; 115(2):713-21. PubMed ID: 26481489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.